You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal cell carcinoma (RCC)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Renal Cell Carcinoma Trial in Rochester (Carevive software)

Recruiting
  • Advanced Renal Cell Carcinoma
  • Carevive software
  • Rochester, New York
    University of Rochester - Wilmot Cancer Institute
Jan 4, 2022

NSCLC, Melanoma, Renal Cell Carcinoma Trial in Haifa (BMC128, Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Haifa, Israel
    Rambam MC
Aug 1, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Systemic Treatments in FH-deficient RCC

Recruiting
  • Metabolomics
  • +3 more
  • Sequencing
  • Shanghai, China
    Yunze Xu
Aug 15, 2022

VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)

Active, not recruiting
  • VHL - Von Hippel-Lindau Syndrome
  • +5 more
  • Bethesda, Maryland
  • +10 more
Aug 16, 2022

Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))

Active, not recruiting
  • Oligoprogressive Renal Cell Carcinoma
  • Stereotactic ablative body radiation (SABR)
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Nov 28, 2022

Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

Recruiting
  • Carcinoma
  • +4 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Jun 30, 2023

    Japanese RCC Patients Treated With Avelumab Plus Axitinib as

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Jan 18, 2023

    Renal Cell Carcinoma Trial (Stereotactic body radiotherapy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Stereotactic body radiotherapy
    • (no location specified)
    Sep 22, 2021

    Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

    Completed
    Has Results
    • Kidney Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 24, 2021

    Multimodal Machine Learning Characterization of Solid Tumors

    Recruiting
    • Adenocarcinoma of Prostate
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Apr 4, 2022

    Advanced Melanoma, Renal Cell Carcinoma Trial in New Haven (Nivolumab, Ipilimumab, APX005M)

    Recruiting
    • Advanced Melanoma
    • Renal Cell Carcinoma
    • New Haven, Connecticut
    • +1 more
    Nov 2, 2021

    Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

    Recruiting
    • Melanoma
    • +14 more
    • LITT + Pembrolizumab
    • Gainesville, Florida
    • +1 more
    Aug 22, 2022

    Melanoma, Renal Cell Carcinoma, NSCLC Trial in United States (HBI-8000 in combination with nivolumab)

    Active, not recruiting
    • Melanoma
    • +2 more
    • HBI-8000 in combination with nivolumab
    • Phoenix, Arizona
    • +5 more
    Jun 11, 2022

    Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

    Not yet recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +2 more
    Jun 27, 2022

    Based on Evidence-based Pathological Diagnose Criteria for RCC

    Not yet recruiting
    • Carcinoma, Renal Cell
    • +3 more
    • Vascular wall invaded
    • (no location specified)
    Oct 18, 2022

    Metastatic Renal Cell Carcinoma Trial in Wien, Essen (Nivolumab, Sunitinib, Pazopanib)

    Terminated
    • Metastatic Renal Cell Carcinoma
    • Wien, Austria
    • +1 more
    Sep 7, 2021

    Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

    Active, not recruiting
    • Advanced Solid Tumors
    • +15 more
    • (no location specified)
    Sep 16, 2022

    Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 Trial in United States

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • +3 more
    • Avelumab
    • +7 more
    • Danville, Illinois
    • +4 more
    Jul 29, 2022

    Database to prospectivelY aSSEss Changing TherapY Landscape in

    Recruiting
    • Metastatic Renal Cell Carcinoma
      • Iowa City, Iowa
      • +7 more
      Oct 13, 2022

      Renal Cell Carcinoma Trial in Australia, Korea, Republic of, United States (Pexastimogene Devacirepvec (Pexa-Vec), Cemiplimab)

      Active, not recruiting
      • Renal Cell Carcinoma
      • Pexastimogene Devacirepvec (Pexa-Vec)
      • Cemiplimab
      • Irvine, California
      • +17 more
      Oct 26, 2022

      Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

      Active, not recruiting
      • Advanced Solid Tumor
      • +3 more
      • TP-1454 monotherapy
      • TP-1454 combination therapy
      • Phoenix, Arizona
      • +8 more
      Nov 18, 2022

      Metastatic Renal Cell Carcinoma Trial in Italy (sorafenib)

      Active, not recruiting
      • Metastatic Renal Cell Carcinoma
      • Milan, Mi, Italy
      • +13 more
      Sep 16, 2021

      Renal Cell Carcinoma Trial in Omaha, Cleveland, Philadelphia (Axitinib)

      Terminated
      Has Results
      • Renal Cell Carcinoma
      • Omaha, Nebraska
      • +2 more
      Jul 26, 2021